Literature DB >> 3745958

Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits.

W Pruzanski, P Vadas, V Fornasier.   

Abstract

Extracellular phospholipase A2 (PLA2) has been found in association with inflamed sites in experimental animals and in humans. The tissue effects of soluble PLA2 have not been defined. We studied the development of inflammatory changes in rabbit skin subsequent to intradermal injection of active and inactivated venom and pancreatic PLA2, over a broad concentration range. PLA2, at concentrations encountered in human disease, caused acute inflammatory changes characterized grossly by erythema and induration, and histologically by inflammatory cell infiltration, vascular and tissue damage, and abscess formation. Extracellular PLA2 may be considered as one of the pathogenic factors in inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745958     DOI: 10.1111/1523-1747.ep12285639

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  18 in total

1.  Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.

Authors:  W Pruzanski; K Scott; G Smith; I Rajkovic; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  A simple and sensitive method for determining transcription initiation site: identification of two transcription initiation sites in rat group II phospholipase A2 gene.

Authors:  O Ohara; J Ishizaki; T Nakano; H Arita; H Teraoka
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 3.  Synovial fluid phospholipase A2s and inflammation.

Authors:  H Gonzalez-Buritica; M A Khamashita; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

4.  Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; S Saito; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

5.  Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells.

Authors:  J Pfeilschifter; W Pignat; J Leighton; F Märki; K Vosbeck; S Alkan
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

6.  The role of phospholipase A2 in calcium-ionophore-mediated injury to rat gastric mucosal cells.

Authors:  B L Tepperman; B D Soper
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.

Authors:  P Vadas; W Pruzanski; J Kim; V Fornasier
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

8.  Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.

Authors:  S Andersen; W Sjursen; A Laegreid; G Volden; B Johansen
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

9.  Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.

Authors:  C Kohler; M Carroll; E Tarrant; L Torley; A Wissner
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

10.  Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

Authors:  P Vadas; W Pruzanski; E Stefanski
Journal:  Agents Actions       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.